Here are relevant reports on : medical-diagnostics-market

• US Veterinary Diagnostics Market by Application (Infectious, Bacterial, Endocrine), Technology (Immunodiagnostic, PCR, ELISA, Lateral Flow), Product (Consumables, Instruments), Animal Type (Dog, Cat, Cattle), End User (POC, Veterinary Labs) – Forecast to 2031

  The US veterinary diagnostics market, valued at USD2.22 billion in 2025, stood at USD2.41 billion in 2026 and is projected to advance at a resilient CAGR of 9.1% from 2026 to 2031, culminating in a forecasted valuation of USD3.74 billion by the end of the period.

  • Published: November 2026
  • Price: $ 4950
  • TOC Available:

• Neuroblastoma Cancer Market by Diagnostics (MIBG Scan, Imaging, Urine Analysis, Biopsy), Treatment (Surgery, Chemotherapy, Radiation therapy, Stem Cell Transplant, Immunotherapy), Staging, Pipeline, Regulatory, Reimbursement - Global Forecast to 2021

  Neuroblastoma is a rare extracranial solid tumor cancer that develops from immature nerve cells found in several areas of the body. It is the most common extracranial solid tumor in childhood.

  • Published: December 2026
  • Price: $ 4950
  • TOC Available:

• In Situ Hybridization Market by Offering (Consumables, Instruments, Software), Technology (FISH (DNA FISH, RNA, PNA), CISH), Application (Cancer Diagnostics, Research, Discovery), End User (Hospitals, Pharma & Biotech, Academia) - Global Forecast to 2030

  The global in situ hybridization market, valued at US$1.55 billion in 2024, stood at US$1.64 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$2.35 billion by the end of the period. The growth in the field of in situ hybridization (ISH) is significantly driven by ongoing advancements in technology, including high-sensitivity probes, automated systems, and multiplexing solutions.

  • Published: June 2025
  • Price: $ 4950
  • TOC Available:

• In Vitro Diagnostics (IVD) Quality Control Market by Product & Service (QC (Plasma, Serum, Blood), Solutions), Technology (Immunoassay, MDx, Microbiology, Hematology), Manufacturer (Third-party, OEM), End User (Hospitals, Labs) - Global Forecast to 2030

  The global IVD quality controls market, valued at US$1.58 billion in 2024, stood at US$1.65 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2030, culminating in a forecasted valuation of US$2.15 billion by the end of the period. The IVD quality controls market is witnessing substantial growth, driven by several key factors.

  • Published: September 2025
  • Price: $ 4950
  • TOC Available:

• Telehealth and Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2031

  The global telehealth and telemedicine market is projected to reach USD 198.9 billion by 2031, growing at a CAGR of 10.9% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: September 2026
  • Price: $ 4950
  • TOC Available:

• Allergy Diagnostics Market by Product & Service (Consumables, Instruments [Immunoassay Analyzers, Luminometers]), Test Type (In Vivo Tests, In Vitro Tests), Allergen (Food Allergens), End User (Hospital-Based Laboratories) - Global Forecast to 2031

  The global Allergy Diagnostics market, valued at USD 6.23 billion in 2025, stood at USD 6.80 billion in 2026 and is projected to advance at a resilient CAGR of 9.6% from 2026 to 2031, culminating in a forecasted valuation of USD 10.77 billion by the end of the period. Allergy diagnostics fit squarely into this paradigm by enabling early detection of sensitization before severe clinical manifestations occur.

  • Published: February 2026
  • Price: $ 4950
  • TOC Available:

• RNA Analysis Market by Product (Reagents, Instruments, Software, Services), Technology (PCR, Sequencing, Microarrays, RNA Interference), Application (Drug Discovery, Clinical Diagnostics), End User (Pharma, Biotech, CROs), Region - Global Forecast to 2028

  The global RNA analysis market, valued at US$4.8 billion in 2022, stood at US$5.3 billion in 2023 and is projected to advance at a resilient CAGR of 13.4% from 2023 to 2028, culminating in a forecasted valuation of US$9.9 billion by the end of the period. Various elements such as increasing R&D activities, increasing government funding for drug discovery research, and growing pharmaceutical & biological industries are the major growth factors for this market.

  • Published: July 2023
  • Price: $ 4950
  • TOC Available:

• Western Blotting Market by Product, (Consumables (Antibody), Instrument (Electrophoresis, Blotting System, Imager (Fluorescent))), Application (Biomedical, Clinical Diagnostics), End User (Research Institute, Hospital, Biopharma) & Region - Global Forecast to 2026

  The global western blotting market growth is primed to transition from $1.0 billion in 2021 to $1.4 billion by 2026, showcasing a strong CAGR of 6.7%. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Medical Animation Market by Type (3D, 2D, 4D), Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), Application (Drug MoA, Patient Education), End User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021

  This report studies the global medical animation market for the forecast period of 2016 to 2021. This market is expected to reach USD 301.3 Million by 2021 from USD 117.3 Million in 2016, at a CAGR of 20.8%. Major players in the medical animation market include Infuse Medical (U.S.), Hybrid Medical Animation, Inc. (U.S.), Ghost Productions, Inc. (U.S.), Scientific Animations, Inc. (U.S.), INVIVO Communications, Inc. (Canada), Random42 Scientific Communication (U.K.), Radius Digital Science (U.S.), Nucleus Medical Media, Inc. (U.S.), AXS Studio, Inc. (Canada), Visible Body (U.S.), Elara Systems, Inc. (U.S.), Animated Biomedical Productions (Australia), XVIVO Scientific Animation (U.S.), Blausen Medical Communications, Inc. (U.S.), Trinsic Medical Animation, LLC. (U.S.), Viscira (U.S.), Understand.com (U.S.), and Medmovie, Inc. (U.S.).

  • Published: May 2016
  • Price: $ 4950
  • TOC Available:

• Bus & Public Transport Fleet Management Market by Operation (Operations Management, Vehicle Maintenance & Diagnostics, Performance Management, Compliance Management), By Fleet Type (Urban Transit, Suburban & Inter-city, Shuttle) - Global Forecast to 2030

  The Bus & Public Transport Fleet Management System Market is projected to reach USD 15.71 billion by 2030, from USD 8.65 billion in 2025, at a CAGR of 12.7% from 2025 to 2030.The key players include Geotab (Canada), Samsara (US), Verizon Connect (US), Webfleet (Netherlands), MiX Telematics (South Africa), Teletrac Navman (US), Fleet Complete (Canada), Zonar Systems (US), ChargePoint (US), Virta (Finland), Driivz (Israel), Siemens (Germany), ABB (Switzerland), Shell (UK), and LocoNav (India).

  • Published: November 2026
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50